Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IRADIMED CORP Director's Dealing 2025

Aug 7, 2025

32324_dirs_2025-08-06_b2f7c30a-e622-4d91-9387-a729c1da8184.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2025-08-06

Reporting Person: ALLEN MONTY K (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-08-06 Common Stock S 1102 $69.10 Disposed 19898 Direct

Footnotes

F1: This transaction was executed in a single trade at the stated price.